Stockscreener 앱 받기
15.59
0.26%
0.04
시간 외 거래:
15.59
전일 마감가:
$15.55
열려 있는:
$15.61
하루 거래량:
537.58K
Relative Volume:
1.07
시가총액:
$633.19M
수익:
-
순이익/손실:
$-168.05M
주가수익비율:
-3.039
EPS:
-5.13
순현금흐름:
$-146.15M
1주 성능:
+2.50%
1개월 성능:
+8.34%
6개월 성능:
+33.59%
1년 성능:
-70.96%
1일 변동 폭
$15.48
$16.00
1주일 범위
$15.22
$16.07
52주 변동 폭
$9.12
$72.37
Keros Therapeutics Inc Stock (KROS) Company Profile
명칭
Keros Therapeutics Inc
전화
617-314-6297
주소
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
KROS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KROS
Keros Therapeutics Inc
|
15.59 | 631.57M | 0 | -168.05M | -146.15M | -5.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-10 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-01-21 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-01-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-12-16 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-12-16 | 재확인 | Oppenheimer | Outperform |
| 2024-12-13 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-12 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-11-05 | 개시 | Jefferies | Buy |
| 2024-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-23 | 개시 | Guggenheim | Buy |
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-02-21 | 개시 | William Blair | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-07-31 | 개시 | Wedbush | Outperform |
| 2023-07-26 | 개시 | BofA Securities | Buy |
| 2023-02-14 | 개시 | Cowen | Outperform |
| 2022-10-18 | 개시 | Truist | Buy |
| 2022-07-26 | 개시 | BTIG Research | Buy |
| 2020-12-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-04 | 개시 | H.C. Wainwright | Buy |
| 2020-05-04 | 개시 | Jefferies | Buy |
| 2020-05-04 | 개시 | Piper Sandler | Overweight |
| 2020-05-04 | 개시 | SVB Leerink | Outperform |
모두보기
Keros Therapeutics Inc 주식(KROS)의 최신 뉴스
What institutional flow reveals about Keros Therapeutics Inc.Portfolio Value Report & Daily Stock Momentum Reports - Newser
What MACD and RSI say about Keros Therapeutics Inc.Weekly Risk Summary & AI Optimized Trading Strategy Guides - Newser
Real time alert setup for Keros Therapeutics Inc. performance2025 Valuation Update & AI Powered Market Trend Analysis - Newser
Keros Therapeutics Inc. stock outlook for YEARPortfolio Risk Report & Fast Gaining Stock Reports - Newser
Keros Therapeutics, Inc. $KROS Shares Sold by Russell Investments Group Ltd. - MarketBeat
464,895 Shares in Keros Therapeutics, Inc. $KROS Purchased by DRW Securities LLC - MarketBeat
Will Keros Therapeutics Inc. benefit from green energy policiesJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - خودرو بانک
Is Keros Therapeutics Inc. backed by strong institutional buyingDollar Strength & Real-Time Sentiment Analysis - خودرو بانک
Can Keros Therapeutics Inc. lead its sector in growthEarnings Recap Report & Daily Profit Focused Stock Screening - خودرو بانک
What candlestick patterns are forming on Keros Therapeutics Inc.July 2025 Selloffs & Verified Momentum Stock Ideas - Newser
Short interest data insights for Keros Therapeutics Inc.Market Sentiment Report & AI Forecast Swing Trade Picks - Newser
Keros Therapeutics Inc. stock trend forecastCPI Data & Fast Gaining Stock Strategy Reports - Newser
How to build a dashboard for Keros Therapeutics Inc. stock2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Can Keros Therapeutics Inc. hit a new high this monthJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Is this a good reentry point in Keros Therapeutics Inc.Weekly Stock Report & Daily Oversold Bounce Ideas - Newser
Exit strategy if you’re trapped in Keros Therapeutics Inc.Jobs Report & Weekly Consistent Profit Watchlists - Newser
Is Keros Therapeutics Inc. forming a breakout patternWeekly Trade Analysis & Weekly High Return Forecasts - خودرو بانک
Jump Financial LLC Takes Position in Keros Therapeutics, Inc. $KROS - MarketBeat
Charles Schwab Investment Management Inc. Sells 37,759 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics, Inc. $KROS Stake Reduced by Alkeon Capital Management LLC - MarketBeat
ADAR1 Capital Management LLC Has $15.15 Million Stock Position in Keros Therapeutics, Inc. $KROS - MarketBeat
Real time social sentiment graph for Keros Therapeutics Inc.2025 Price Targets & Real-Time Price Movement Reports - Newser
276,060 Shares in Keros Therapeutics, Inc. $KROS Purchased by PDT Partners LLC - MarketBeat
Walleye Capital LLC Sells 47,163 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics Inc. stock chart pattern explained2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - Newser
Intraday pattern recognizer results for Keros Therapeutics Inc.2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
Pattern recognition hints at Keros Therapeutics Inc. upside2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Published on: 2025-09-03 23:43:48 - Newser
Analyzing Keros Therapeutics Inc. with risk reward ratio chartsWeekly Trade Recap & Verified Momentum Watchlists - Newser
Is it time to cut losses on Keros Therapeutics Inc.Trade Risk Summary & Long-Term Safe Investment Plans - Newser
Statistical indicators supporting Keros Therapeutics Inc.’s strengthPortfolio Risk Summary & Comprehensive Market Scan Reports - Newser
Applying chart zones and confluence areas to Keros Therapeutics Inc.IPO Watch & Safe Capital Growth Trade Ideas - Newser
Does Keros Therapeutics Inc. qualify in momentum factor screening2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - Newser
Technical signs of recovery in Keros Therapeutics Inc.Portfolio Update Summary & Safe Capital Growth Tips - Newser
How to escape a deep drawdown in Keros Therapeutics Inc.Analyst Upgrade & Weekly Watchlist of Top Performers - Newser
Published on: 2025-09-03 02:58:10 - Newser
Tick level data insight on Keros Therapeutics Inc. volatilityJuly 2025 Outlook & Daily Momentum Trading Reports - Newser
Vanguard Group Inc. Has $26.15 Million Stock Holdings in Keros Therapeutics, Inc. $KROS - MarketBeat
Leading vs lagging indicators on Keros Therapeutics Inc. performanceJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Keros Therapeutics shares rise 1.46% after-hours following the release of DelveInsight's TGFB Inhibitor Pipeline Outlook 2025 report. - AInvest
Will Keros Therapeutics Inc. stock go up soonJuly 2025 Opening Moves & Expert Verified Stock Movement Alerts - Newser
Using AI based signals to follow Keros Therapeutics Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser
What is the target price for Keros Therapeutics Inc. stock2025 Year in Review & Fast Gaining Stock Reports - خودرو بانک
Does Keros Therapeutics Inc. stock have upside surprise potentialWeekly Earnings Recap & Stock Timing and Entry Methods - خودرو بانک
Keros Therapeutics Inc (KROS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Keros Therapeutics Inc 주식 (KROS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Seehra Jasbir | CHIEF EXECUTIVE OFFICER |
Apr 04 '25 |
Option Exercise |
0.30 |
49,367 |
14,810 |
302,223 |
1.40%
자본화:
|
볼륨(24시간):